Financhill
Buy
64

IOSP Quote, Financials, Valuation and Earnings

Last price:
$106.59
Seasonality move :
7.88%
Day range:
$107.29 - $110.47
52-week range:
$103.97 - $133.71
Dividend yield:
1.44%
P/E ratio:
18.80x
P/S ratio:
1.44x
P/B ratio:
2.16x
Volume:
84.8K
Avg. volume:
130.9K
1-year change:
-9.45%
Market cap:
$2.7B
Revenue:
$1.9B
EPS (TTM):
$5.73

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
IOSP
Innospec
$447.4M $1.37 -9.56% -9.49% --
ALTO
Alto Ingredients
$222.8M -$0.11 6.73% -57.69% --
BCPC
Balchem
$240M $1.11 4.92% 34.76% --
FRD
Friedman Industries
-- -- -- -- --
PZG
Paramount Gold Nevada
-- -$0.03 -- -- --
XPL
Solitario Resources
-- -$0.02 -- -- $1.50
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
IOSP
Innospec
$107.71 -- $2.7B 18.80x $0.79 1.44% 1.44x
ALTO
Alto Ingredients
$1.83 -- $140.3M -- $0.00 0% 0.13x
BCPC
Balchem
$157.16 -- $5.1B 42.25x $0.87 0.55% 5.44x
FRD
Friedman Industries
$15.19 -- $105.8M 13.32x $0.04 0.92% 0.23x
PZG
Paramount Gold Nevada
$0.36 -- $23.7M -- $0.00 0% --
XPL
Solitario Resources
$0.60 $1.50 $49M -- $0.00 0% --
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
IOSP
Innospec
-- 1.610 -- 1.69x
ALTO
Alto Ingredients
24% -0.580 67.56% 1.90x
BCPC
Balchem
16.17% 1.859 3.97% 1.77x
FRD
Friedman Industries
21.78% 0.211 32.37% 1.16x
PZG
Paramount Gold Nevada
-- 0.990 -- --
XPL
Solitario Resources
-- -1.136 -- --
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
IOSP
Innospec
$124.1M $47.9M 12.17% 12.17% 10.8% $61.7M
ALTO
Alto Ingredients
$6M -$1.6M -10.1% -13.16% -0.23% $18.1M
BCPC
Balchem
$85.4M $48M 8.77% 11.16% 19.99% $42.2M
FRD
Friedman Industries
$10.1M -$2K 4.68% 6.32% -0.03% $8.9M
PZG
Paramount Gold Nevada
-$166.6K -$1.4M -- -- -- -$1.2M
XPL
Solitario Resources
-$8K -$2.5M -- -- -- -$1.8M

Innospec vs. Competitors

  • Which has Higher Returns IOSP or ALTO?

    Alto Ingredients has a net margin of 7.53% compared to Innospec's net margin of -0.97%. Innospec's return on equity of 12.17% beat Alto Ingredients's return on equity of -13.16%.

    Company Gross Margin Earnings Per Share Invested Capital
    IOSP
    Innospec
    27.99% $1.33 $1.2B
    ALTO
    Alto Ingredients
    2.37% -$0.04 $347.3M
  • What do Analysts Say About IOSP or ALTO?

    Innospec has a consensus price target of --, signalling upside risk potential of 21.62%. On the other hand Alto Ingredients has an analysts' consensus of -- which suggests that it could grow by 145.9%. Given that Alto Ingredients has higher upside potential than Innospec, analysts believe Alto Ingredients is more attractive than Innospec.

    Company Buy Ratings Hold Ratings Sell Ratings
    IOSP
    Innospec
    0 0 0
    ALTO
    Alto Ingredients
    0 0 0
  • Is IOSP or ALTO More Risky?

    Innospec has a beta of 1.093, which suggesting that the stock is 9.261% more volatile than S&P 500. In comparison Alto Ingredients has a beta of 1.869, suggesting its more volatile than the S&P 500 by 86.907%.

  • Which is a Better Dividend Stock IOSP or ALTO?

    Innospec has a quarterly dividend of $0.79 per share corresponding to a yield of 1.44%. Alto Ingredients offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Innospec pays 25.23% of its earnings as a dividend. Alto Ingredients pays out -4.52% of its earnings as a dividend. Innospec's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios IOSP or ALTO?

    Innospec quarterly revenues are $443.4M, which are larger than Alto Ingredients quarterly revenues of $251.8M. Innospec's net income of $33.4M is higher than Alto Ingredients's net income of -$2.4M. Notably, Innospec's price-to-earnings ratio is 18.80x while Alto Ingredients's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Innospec is 1.44x versus 0.13x for Alto Ingredients. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    IOSP
    Innospec
    1.44x 18.80x $443.4M $33.4M
    ALTO
    Alto Ingredients
    0.13x -- $251.8M -$2.4M
  • Which has Higher Returns IOSP or BCPC?

    Balchem has a net margin of 7.53% compared to Innospec's net margin of 14.1%. Innospec's return on equity of 12.17% beat Balchem's return on equity of 11.16%.

    Company Gross Margin Earnings Per Share Invested Capital
    IOSP
    Innospec
    27.99% $1.33 $1.2B
    BCPC
    Balchem
    35.58% $1.03 $1.4B
  • What do Analysts Say About IOSP or BCPC?

    Innospec has a consensus price target of --, signalling upside risk potential of 21.62%. On the other hand Balchem has an analysts' consensus of -- which suggests that it could grow by 21.11%. Given that Innospec has higher upside potential than Balchem, analysts believe Innospec is more attractive than Balchem.

    Company Buy Ratings Hold Ratings Sell Ratings
    IOSP
    Innospec
    0 0 0
    BCPC
    Balchem
    0 0 0
  • Is IOSP or BCPC More Risky?

    Innospec has a beta of 1.093, which suggesting that the stock is 9.261% more volatile than S&P 500. In comparison Balchem has a beta of 0.686, suggesting its less volatile than the S&P 500 by 31.375%.

  • Which is a Better Dividend Stock IOSP or BCPC?

    Innospec has a quarterly dividend of $0.79 per share corresponding to a yield of 1.44%. Balchem offers a yield of 0.55% to investors and pays a quarterly dividend of $0.87 per share. Innospec pays 25.23% of its earnings as a dividend. Balchem pays out 21.07% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios IOSP or BCPC?

    Innospec quarterly revenues are $443.4M, which are larger than Balchem quarterly revenues of $239.9M. Innospec's net income of $33.4M is lower than Balchem's net income of $33.8M. Notably, Innospec's price-to-earnings ratio is 18.80x while Balchem's PE ratio is 42.25x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Innospec is 1.44x versus 5.44x for Balchem. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    IOSP
    Innospec
    1.44x 18.80x $443.4M $33.4M
    BCPC
    Balchem
    5.44x 42.25x $239.9M $33.8M
  • Which has Higher Returns IOSP or FRD?

    Friedman Industries has a net margin of 7.53% compared to Innospec's net margin of -0.63%. Innospec's return on equity of 12.17% beat Friedman Industries's return on equity of 6.32%.

    Company Gross Margin Earnings Per Share Invested Capital
    IOSP
    Innospec
    27.99% $1.33 $1.2B
    FRD
    Friedman Industries
    9.5% -$0.10 $164.6M
  • What do Analysts Say About IOSP or FRD?

    Innospec has a consensus price target of --, signalling upside risk potential of 21.62%. On the other hand Friedman Industries has an analysts' consensus of -- which suggests that it could fall by --. Given that Innospec has higher upside potential than Friedman Industries, analysts believe Innospec is more attractive than Friedman Industries.

    Company Buy Ratings Hold Ratings Sell Ratings
    IOSP
    Innospec
    0 0 0
    FRD
    Friedman Industries
    0 0 0
  • Is IOSP or FRD More Risky?

    Innospec has a beta of 1.093, which suggesting that the stock is 9.261% more volatile than S&P 500. In comparison Friedman Industries has a beta of 1.411, suggesting its more volatile than the S&P 500 by 41.118%.

  • Which is a Better Dividend Stock IOSP or FRD?

    Innospec has a quarterly dividend of $0.79 per share corresponding to a yield of 1.44%. Friedman Industries offers a yield of 0.92% to investors and pays a quarterly dividend of $0.04 per share. Innospec pays 25.23% of its earnings as a dividend. Friedman Industries pays out 3.35% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios IOSP or FRD?

    Innospec quarterly revenues are $443.4M, which are larger than Friedman Industries quarterly revenues of $106.8M. Innospec's net income of $33.4M is higher than Friedman Industries's net income of -$675K. Notably, Innospec's price-to-earnings ratio is 18.80x while Friedman Industries's PE ratio is 13.32x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Innospec is 1.44x versus 0.23x for Friedman Industries. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    IOSP
    Innospec
    1.44x 18.80x $443.4M $33.4M
    FRD
    Friedman Industries
    0.23x 13.32x $106.8M -$675K
  • Which has Higher Returns IOSP or PZG?

    Paramount Gold Nevada has a net margin of 7.53% compared to Innospec's net margin of --. Innospec's return on equity of 12.17% beat Paramount Gold Nevada's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    IOSP
    Innospec
    27.99% $1.33 $1.2B
    PZG
    Paramount Gold Nevada
    -- -$0.02 --
  • What do Analysts Say About IOSP or PZG?

    Innospec has a consensus price target of --, signalling upside risk potential of 21.62%. On the other hand Paramount Gold Nevada has an analysts' consensus of -- which suggests that it could grow by 234.92%. Given that Paramount Gold Nevada has higher upside potential than Innospec, analysts believe Paramount Gold Nevada is more attractive than Innospec.

    Company Buy Ratings Hold Ratings Sell Ratings
    IOSP
    Innospec
    0 0 0
    PZG
    Paramount Gold Nevada
    0 0 0
  • Is IOSP or PZG More Risky?

    Innospec has a beta of 1.093, which suggesting that the stock is 9.261% more volatile than S&P 500. In comparison Paramount Gold Nevada has a beta of 1.881, suggesting its more volatile than the S&P 500 by 88.144%.

  • Which is a Better Dividend Stock IOSP or PZG?

    Innospec has a quarterly dividend of $0.79 per share corresponding to a yield of 1.44%. Paramount Gold Nevada offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Innospec pays 25.23% of its earnings as a dividend. Paramount Gold Nevada pays out -- of its earnings as a dividend. Innospec's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios IOSP or PZG?

    Innospec quarterly revenues are $443.4M, which are larger than Paramount Gold Nevada quarterly revenues of --. Innospec's net income of $33.4M is higher than Paramount Gold Nevada's net income of -$1.6M. Notably, Innospec's price-to-earnings ratio is 18.80x while Paramount Gold Nevada's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Innospec is 1.44x versus -- for Paramount Gold Nevada. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    IOSP
    Innospec
    1.44x 18.80x $443.4M $33.4M
    PZG
    Paramount Gold Nevada
    -- -- -- -$1.6M
  • Which has Higher Returns IOSP or XPL?

    Solitario Resources has a net margin of 7.53% compared to Innospec's net margin of --. Innospec's return on equity of 12.17% beat Solitario Resources's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    IOSP
    Innospec
    27.99% $1.33 $1.2B
    XPL
    Solitario Resources
    -- -$0.03 --
  • What do Analysts Say About IOSP or XPL?

    Innospec has a consensus price target of --, signalling upside risk potential of 21.62%. On the other hand Solitario Resources has an analysts' consensus of $1.50 which suggests that it could grow by 149.46%. Given that Solitario Resources has higher upside potential than Innospec, analysts believe Solitario Resources is more attractive than Innospec.

    Company Buy Ratings Hold Ratings Sell Ratings
    IOSP
    Innospec
    0 0 0
    XPL
    Solitario Resources
    0 0 0
  • Is IOSP or XPL More Risky?

    Innospec has a beta of 1.093, which suggesting that the stock is 9.261% more volatile than S&P 500. In comparison Solitario Resources has a beta of 0.890, suggesting its less volatile than the S&P 500 by 10.984%.

  • Which is a Better Dividend Stock IOSP or XPL?

    Innospec has a quarterly dividend of $0.79 per share corresponding to a yield of 1.44%. Solitario Resources offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Innospec pays 25.23% of its earnings as a dividend. Solitario Resources pays out -- of its earnings as a dividend. Innospec's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios IOSP or XPL?

    Innospec quarterly revenues are $443.4M, which are larger than Solitario Resources quarterly revenues of --. Innospec's net income of $33.4M is higher than Solitario Resources's net income of -$2.3M. Notably, Innospec's price-to-earnings ratio is 18.80x while Solitario Resources's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Innospec is 1.44x versus -- for Solitario Resources. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    IOSP
    Innospec
    1.44x 18.80x $443.4M $33.4M
    XPL
    Solitario Resources
    -- -- -- -$2.3M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is SCHD a Good ETF to Buy?
Is SCHD a Good ETF to Buy?

With around $65.7 billion in net assets, Schwab’s US Dividend…

Is NAIL a Good ETF to Buy?
Is NAIL a Good ETF to Buy?

If you’re thinking about buying the NAIL ETF, this article…

3 High Dividend Dow Jones Stocks
3 High Dividend Dow Jones Stocks

Thanks to surging stock prices over the past two years,…

Stock Ideas

Sell
42
Is AAPL Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 40x

Buy
59
Is NVDA Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 125x

Sell
46
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 36x

Alerts

Sell
50
NARI alert for Jan 7

Inari Medical [NARI] is up 22.25% over the past day.

Buy
70
PDEX alert for Jan 7

Pro-Dex [PDEX] is down 10.89% over the past day.

Buy
52
ALCO alert for Jan 7

Alico [ALCO] is down 3.89% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock